Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer
- PMID: 27391432
- PMCID: PMC5226593
- DOI: 10.18632/oncotarget.10416
Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer
Abstract
Liver metastasis is the primary cause of death for colorectal cancer (CRC) patients. To investigate the prognostic value of long non-coding RNAs (lncRNAs) on colorectal liver metastases, quantitative reverse-transcriptase PCR (quantitative RT-PCR) was performed on 15 lncRNAs in 51 stage IV CRC with liver metastases and 57 stage I/II CRC specimens. The expression levels of four lncRNAs (GAS5, H19, MEG3 and Yiya) were significantly different between liver metastases and primary tumors of stage IV CRC patients. Furthermore, the high expression levels of GAS5 and Yiya were significantly associated with future occurrence of liver metastases in early stage CRC patients. Kaplan-Meier analysis showed that the high expression levels of GAS5 or Yiya were correlated with poor prognosis of early stage CRC patients (p = 0.0206 and 0.0005 for GAS5 and Yiya, respectively). Yiya expression was proved to be an independent prognostic indicator of colorectal liver metastases in a multivariate analysis (relative risk = 10.7; p < 0.0001). Our study revealed that GAS5 and Yiya were promising prognostic biomarkers of liver metastases for early stage CRC patients.
Keywords: early stage colorectal cancer; liver metastasis; long non-coding RNA; prognostic biomarker; quantitative RT-PCR.
Conflict of interest statement
The authors declare no conflicts of interests.
Figures
Similar articles
-
Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.J Cell Physiol. 2019 May;234(5):7032-7039. doi: 10.1002/jcp.27456. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317592
-
Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.Cancer Biomark. 2018;22(2):283-299. doi: 10.3233/CBM-171011. Cancer Biomark. 2018. PMID: 29630521
-
Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.Tumour Biol. 2015 Nov;36(11):8747-54. doi: 10.1007/s13277-015-3627-4. Epub 2015 Jun 7. Tumour Biol. 2015. PMID: 26050227
-
Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.Adv Exp Med Biol. 2016;937:183-204. doi: 10.1007/978-3-319-42059-2_10. Adv Exp Med Biol. 2016. PMID: 27573901 Review.
-
Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.Microrna. 2018;7(3):167-177. doi: 10.2174/2211536607666180525073302. Microrna. 2018. PMID: 29793419 Review.
Cited by
-
Long non-coding RNAs: a rising biotarget in colorectal cancer.Oncotarget. 2017 Mar 28;8(13):22187-22202. doi: 10.18632/oncotarget.14728. Oncotarget. 2017. PMID: 28108736 Free PMC article. Review.
-
Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated.Cancer Cell Int. 2022 Nov 8;22(1):341. doi: 10.1186/s12935-022-02766-w. Cancer Cell Int. 2022. PMID: 36348319 Free PMC article. Review.
-
LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer.World J Gastroenterol. 2019 Aug 7;25(29):3972-3984. doi: 10.3748/wjg.v25.i29.3972. World J Gastroenterol. 2019. PMID: 31413531 Free PMC article.
-
Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors.World J Gastroenterol. 2019 Sep 14;25(34):5026-5048. doi: 10.3748/wjg.v25.i34.5026. World J Gastroenterol. 2019. PMID: 31558855 Free PMC article. Review.
-
Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.J Transl Med. 2018 Feb 28;16(1):46. doi: 10.1186/s12967-018-1418-6. J Transl Med. 2018. PMID: 29490660 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895–904. - PubMed
-
- National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER 18) Program. SEER Stat Fact Sheets: Colon and Rectum Cancer. 2015 Mar; http://seer.cancer.gov/statfacts/html/colorect.html
-
- Turner JR, Lingen MW. Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Philadelphia, PA: ELSEVIER SAUNDERS; 2013. Oral Cavity and Gastrointestinal Track; pp. 596–600.
-
- Siriwardena AK, Mason JM, Mullamitha S, Hancock HC, Jegatheeswaran S. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol. 2014;11:446–59. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical